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ABSTRACT
Introduction: Given the promising advantages of
upper extremity home-based programmes in children
with cerebral palsy (CP), a systematic review of the
available literature on this topic is warranted.
The purpose of the systematic review described
in this protocol is to investigate currently
available home-based occupational therapy and
physiotherapy programmes regarding both their
feasibility and effect.
Methods and analysis: This protocol describes a
systematic review, developed in accordance with the
Preferred Reporting Items for Systematic Review and
Meta-Analysis Protocols (PRISMA-P) 2015. Studies
will be included in which primary data are collected,
participants are children aged <18 years with any type
of CP and the intervention of interest is a home-based
occupational therapy or physiotherapy intervention.
Comparators of interest are: no therapy, care as usual,
centre-based occupational therapy or physiotherapy, an
alternative home-based programme and a medical
intervention. Studies will be included that report either
on feasibility (ie, acceptability, demand,
implementation, practicality, adaptation, expansion or
integration) or on efficacy/effectiveness (ie, child-
related upper extremity outcomes within all
International Classification of Functioning, Disability
and Health levels or parent-related/caregiver-related
outcomes on the psychological and social domain).
Relevant studies will be identified by searching the
databases MEDLINE, EMBASE, CINAHL, PsycINFO,
PEDro, OTSeeker and CPCI-S as well as the trial
registers ICTRP and CENTRAL, the reference lists of
included records and by circulating a bibliography of
the included records to authors of included studies.
There will be no restrictions on language or year of
publication. The search strategy consists of
terms related to the population and intervention.
Data will be extracted in duplicate using a digital data
extraction form.
Ethics and dissemination: The proposed study
does not involve collection of primary data.
Accordingly, no ethical approval is required. The
authors will disseminate the findings of this systematic
review through publication in a peer-reviewed journal
and conference presentation(s).
Trial registration number: CRD42016043743;
pre-results.
INTRODUCTION
Cerebral palsy (CP) is one of the most
common causes of physical disability in chil-
dren. The majority of children with CP have
impaired arm-hand function.1 Abundant
research has shown the effectiveness of
centre-based therapies in children with CP,
including upper extremity interventions such
as constraint-induced movement therapy and
bimanual training.2–5
In recent years, home-based programmes
have received increasing attention in rehabili-
tation of children with CP. These programmes
Strengths and limitations of this study
▪ The systematic review described in this protocol
will be the first review to be systematic as well
as specifically focused on home-based occupa-
tional therapy and physiotherapy programmes in
children with cerebral palsy.
▪ By systematic review, feasibility as well as effect
will be investigated.
▪ In the systematic review, both child-related and
parent-related outcomes will be included.
▪ During the systematic review, selection of
records, data collection, assessment of the risk
of bias and judgement of the quality of evidence
will be performed in duplicate, independently by
two reviewers.
▪ It is anticipated that no meta-analysis can be
conducted due to the expected clinical and meth-
odological heterogeneity of reports.
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are a useful addition to centre-based occupational
therapy and physiotherapy for a number of reasons.
First, home-based programmes provide a unique oppor-
tunity to continue aspects of therapy, either in between
centre-based sessions or after centre-based therapy has
ended. This beneﬁts the retention of established inter-
vention effects. Second, they increase parental involve-
ment and empowerment, in turn contributing to
reciprocal partnerships between parents and health pro-
fessionals. This enables parents and health professionals
to learn from each other and share each other’s per-
spectives on the rehabilitation of the child. Third, home-
based programmes anticipate changes in the healthcare
system by providing a treatment approach that is consid-
ered to be cost-effective. Fourth, and ﬁnally, home-based
programmes may be the preferred or even the only feas-
ible option in speciﬁc contexts, for example, in cases
where long distances need to be travelled from the
child’s home to the institution. Given these promising
advantages of home-based programmes in children with
CP, a systematic review of the available literature on this
topic is warranted.
In a recent study, Sakzewski et al6 provided a systematic
overview of non-surgical upper extremity therapies in
children with unilateral CP and argued that treatment at
home may be an effective supplement to centre-based
interventions. In the same year, Novak and Berry7
focused on the effectiveness of home-based programmes
in children with CP. In contrast to the study of Sakzewski
et al, the review of Novak et al was not systematic. Similar
to Sakzewski et al however, they concluded that home-
based programmes using goal directed training are
effective for improving motor outcomes.7 To extend the
two previous studies, the review described in this proto-
col will be systematic as well as speciﬁcally focused on
home-based interventions in children with CP. The
review will be distinctive because its purpose is to investi-
gate currently available home-based occupational
therapy and physiotherapy programmes regarding both
their feasibility and their effect, and to evaluate both
child-related and parent-related outcomes.
Feasibility will be addressed, as this is a prerequisite
for effective home-based programmes. Since feasibility is
a general facet of home-based programmes per se, the
review will not be limited to feasibility of upper extrem-
ity programmes. Feasibility of a variety of home-based
occupational therapy and physiotherapy programmes
will be reviewed. In contrast, the review of the effect will
indeed be limited to home-based programmes that focus
on the upper extremity.
Both efﬁcacy and effectiveness will be addressed.
Efﬁcacy and effectiveness are related concepts, but with
an important difference between them. Efﬁcacy relates
to results of an intervention under ideal circumstances
(ie, explanatory study). Effectiveness, on the other hand,
relates to the beneﬁcial effect of an intervention under
‘real world’ clinical settings (ie, pragmatic study).8
Parents play a key role in a home-based programme for
their child. Hence, their contribution to the programme
might affect their psychosocial health, either positive or
negative, which may inﬂuence the adherence to the pro-
gramme. Therefore, next to child-related outcomes,
parent-related outcomes are of primary interest in our
evaluation of efﬁcacy and effectiveness of home-based
programmes.
Comparison of effectiveness of different upper extrem-
ity home-based programmes is critical for clinical
decision-making when considering options for individual
treatment plans, or for institutional decision-making.
Moreover, detailed insight into different home-based
programmes regarding feasibility, efﬁcacy as well as
effectiveness will result in recommendations to improve
existing home-based programmes and to develop and
design of new programmes.
Objectives
The aim of the systematic review described in this proto-
col is to provide a clear view on the available home-
based occupational therapy and physiotherapy pro-
grammes in children with CP (aged <18 years), speciﬁc-
ally home-based programmes that focus on the upper
extremity. Two objectives will be addressed by the system-
atic review:
1. To assess the feasibility of home-based occupational
therapy and physiotherapy programmes in children
with CP.
2. To assess the efﬁcacy and effectiveness of home-based
occupational therapy and physiotherapy programmes
that focus on the upper extremity in children with
CP, on child-related and parent-related outcomes.
METHODS AND ANALYSIS
Design
The protocol for the systematic review was developed in
accordance with the Preferred Reporting Items for
Systematic Review and Meta-Analysis Protocols
(PRISMA-P) 2015.9 10
Eligibility criteria
Study designs
Studies in which primary data were collected will be
included. That is, (systematic) reviews and meta-analyses
will be excluded. A relatively small number of available
studies are expected.7 Since it is strived for an overview
of all available evidence, all types of study designs will be
included regarding feasibility as well as efﬁcacy and
effectiveness. However, the hierarchy of evidence will be
taken into consideration for reporting of the results of
the review.
Participants
Studies on children aged <18 years with any type of CP
will be included. Studies in which adult patients partici-
pated in the home-based programme next to children
will also be included, provided that data were reported
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separately for children and adults (aged ≥18 years).
Likewise, studies in which both children with CP and
children with other disorders were studied will also be
included, provided that data of children with CP were
reported separately.
Interventions and setting
Studies that report on at least one home-based occupa-
tional therapy or physiotherapy intervention will be
included. An intervention is considered to be home-
based if treatment is performed in the home setting
without a healthcare provider being physically present.
Studies that only include therapy provided at a health-
care facility, (pre)school or day care will be excluded. In
case the intervention takes place in different settings,
studies will be included if treatment of the child in the
home setting is a fundamental, prespeciﬁed element of
the intervention. Regarding the research objective on
efﬁcacy/effectiveness, exclusively studies that report on
interventions targeting the upper extremity will be
included. Hence, studies that report on general gross
motor function will be excluded.
We consider home-based programmes as complex
interventions, composed of several interacting compo-
nents. Possible components could be, for example, train-
ing of the parents, exercises or supervision by a
healthcare professional. Where possible, feasibility, efﬁ-
cacy or effectiveness of components will be described
separately.
Comparators
The nature of the comparator (ie, the intervention
against which the home-based programme is compared)
is unrelated to the feasibility of the home-based pro-
gramme. Hence, to describe the feasibility of home-based
programmes, studies on all possible control interventions
will be included as well as studies without one.
To assess efﬁcacy/effectiveness, comparators of inter-
est are: no therapy, care as usual, centre-based occupa-
tional therapy or physiotherapy, and medical
intervention (ie, drugs or a surgical procedure such as
botulinum toxin injections). Studies in which two or
more home-based programmes were compared with
each other will also be included.
Outcomes
To determine feasibility, studies will be included that
reported on outcomes within the areas acceptability,
demand, implementation, practicality, adaptation,
expansion and integration.11 These terms will be elabo-
rated on in the paragraph on ‘Outcomes and
prioritisation’.
With regard to efﬁcacy and effectiveness, the out-
comes of interest are:
▸ Child-related outcomes within all levels of the
International Classiﬁcation of Functioning, Disability
and Health (ICF), that is, body functions and struc-
tures, activity and participation.12
▸ Parent-related or caregiver-related outcomes on the
psychological and social domain.
Studies reporting on at least one of the aforemen-
tioned outcomes regarding feasibility, efﬁcacy or effect-
iveness will be included.
Timing
There will be no restrictions on the length of follow-up
to assess outcomes.
Language
There will be no language restrictions.
Information sources
Several complementary information sources will be used
to identify relevant studies, applying the strategy
described in the next paragraph. Also, unpublished
studies will be searched for. There will be no restriction
on the year of publication. First, the following electronic
databases will be searched for literature: MEDLINE
(Ovid interface), EMBASE (Ovid interface) CINAHL
(EBSCO interface), PsycINFO (EBSCO interface),
CPCI-S (Web of Science interface), OTseeker and PEDro.
The search will be supplemented by searching for trial
protocols through the trial register ICTRP. Until reaching
a point of literature saturation (ie, the moment when no
new relevant studies emerge), the reference lists of
included records will be scrutinised, as well as the refer-
ence lists of (systematic) reviews and meta-analysis that
were found during the search. Titles and abstracts of the
references will be compared with the eligibility criteria to
decide on inclusion in the selection process. Finally, a
bibliography of the included records will be circulated to
all corresponding and last authors of included studies.
They will be asked to provide details of any other related
study either by their research group or associates.
Search strategy
The search strategy includes keywords (eg, MESH-terms)
and text words (ie, within title and abstract), combining
population and intervention-related search terms, for
example:
MEDLINE search—Ovid interface
1. Cerebral Palsy/
2. ((cerebral adj2 pals$) or encephalopathia infantalis
or spastic diplegia$ or little$ disease).ti,ab.
3. or/1–2
4. exp Self Care/
5. Home Care Services/
6. (Home or in?home or home?based or self care or
residence or domiciliary).ti,ab.
7. or/4–6
8. exp Exercise Therapy/
9. Physical Therapy Modalities/
10. (Exercise$ or therapy or therapies or program$ or
train$ or physiotherapy$ or occupational or (phys-
ical adj2 therap$)).ti,ab.
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11. or/8–10
12. 3 and 7 and 11
Two members of the research team (LWMEB and JK)
developed the search strategy for each database and trial
register. JK will perform the search.
Study records
Data management
Literature search results and corresponding PDF ﬁles
will be uploaded to the reference management software
EndNote. EndNote will be used to remove duplicate
records. All records will be uploaded in Covidence. This
program will be used for selection, data collection and
maintenance of the review.
Selection process
Before the selection process starts, search results of the
various information sources will be merged and dupli-
cate records will be removed. The ﬁrst phase of the
selection process consists of the screening of titles and
abstracts on eligibility criteria such that irrelevant
records are removed. In case of any doubt regarding
relevance, the record will remain included at this stage.
Subsequently, full texts will be retrieved for all poten-
tially relevant records. Full-text records will be examined
for compliance of studies with the eligibility criteria.
Records for which the full text cannot be retrieved may
also be included, although results will be reported separ-
ately. Multiple records of the same study will be identi-
ﬁed and handled as described in the paragraph ‘data
collection process’.
The ﬁrst phase of the selection process (ie, screening
of titles and abstracts) will be performed in duplicate by
two independent reviewers (LWMEB and MLAPS).
Examination of the full-text records will be performed
in duplicate and independently by the same reviewers
(LWMEB and MLAPS), who will not be blinded to any
study information. Inter-rater agreement will be calcu-
lated. In case of discrepancies in any phase of the selec-
tion process, a third and fourth reviewer (YJJ-P and BS)
will mediate to reach consensus.
Data collection process
Data extraction will be carried out by use of Covidence,
in duplicate by two independent reviewers (LWMEB and
MLAPS). To increase consistency between the reviewers,
the data extraction form will be pilot tested before the
start of the data collection process of the review. This
will be carried out by duplicate completion of the form
for two CP-related records (one feasibility study and one
randomised controlled trial), which are not eligible for
inclusion in this review (LWMEB and MLAPS).
Adaptations will be processed based on discrepancy
between the data extraction results of the reviewers, eval-
uated by a third reviewer (YJJ-P) and the reviewers’
experiences during the pilot test. In case of discrepan-
cies between the reviewers during the review, a third and
fourth reviewer (YJJ-P and BS) will arbitrate to reach
consensus.
In the absence of complete descriptions of essential
information, the reviewers will contact the correspon-
ding author to collect the required information. The
decision to contact an author will be made in mutual
agreement between the four reviewers (LWMEB,
MLAPS, YJJ-P and BS). On the basis of an earlier study,
it is expected to receive additional information for
∼50% of the incompletely described studies.13
Multiple records of a single study will be searched for
by comparing author names, intervention locations,
intervention characteristics, sample sizes and outcomes
of eligible records. If multiple records present different
outcome variables or time points, they will be combined
into one record within the review. If overlapping records
on the same outcome variable(s) as well as the same
time points are found, only the one reporting on the
largest sample size will be included in the review. This
will avoid double-counting of participants. In case of
inconsistencies between reports, the reviewers will
contact the authors for clariﬁcation, using the same
approach mentioned earlier in this paragraph.
Data items
From all records, the following information will be
extracted: author(s), publication date, study design,
country, comparator, number of participants (in total
and per study arm), outcomes, duration of follow-up
and time points of measurements.
The following treatment characteristics of the home-
based programmes will be extracted: objective, therapy
provider(s), duration of the programme, frequency and
duration of sessions, treatment approach (eg, task-
speciﬁc training). Furthermore, demographics of partici-
pating children will be extracted: age, gender, diagnosis
(including type and topographical distribution of CP),
level on the Manual Ability Classiﬁcation System, level
on the Gross Motor Function Classiﬁcation System and
level on the Communication Function Classiﬁcation
System. Finally, the demographics of parents of partici-
pating children will be extracted: age, gender and edu-
cational level. The data extracted from the included
studies will be summarised and tabulated.
Outcomes and prioritisation
Concerning the feasibility objective, the following areas
of outcomes will be applied:11
Primary outcome:
▸ Acceptability: ‘the extent to which programme deli-
verers or programme recipients judge the programme
as suitable, satisfying or attractive (eg, satisfaction)’.
Secondary outcomes:
▸ Demand: ‘the extent to which a programme is likely to
be used (eg, expressed interest to use)’.
▸ Implementation: ‘the extent to which a programme can
successfully be delivered to intended participants in
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some deﬁned, but not fully controlled, context (eg,
success or failure of execution)’.
▸ Practicality: ‘the extent to which a programme can be
carried out with intended participants using existing
means, resources and circumstances and without
outside intervention (eg, ability of participants to
carry out intervention activities)’.
▸ Adaptation: ‘the extent to which an existing pro-
gramme performs when changes are made regarding
format or population (eg, degree to which similar
outcomes are obtained in a new format)’.
▸ Integration: ‘the extent to which a programme can be
integrated within an existing system (eg, perceived
sustainability)’.
▸ Expansion: ‘the extent to which a previously tested
programme can be expanded to provide a new pro-
gramme or service (eg, positive or negative effects on
organisation)’.
For the efﬁcacy and effectiveness studies, the following
outcomes will be used:
Primary outcomes:
▸ Child-related upper extremity outcomes within the
level activity of the ICF (eg, Assisting Hand Assessment).
Secondary outcomes:
▸ Child-related upper extremity outcomes within the
levels body functions and structures and participation of
the ICF (eg, spasticity assessment and Children’s
Assessment of Participation and Enjoyment,
respectively).
▸ Parent-related or caregiver-related outcomes within
the psychological and social domain (eg, Parenting
Stress Index).
If available, results from an intention-to-treat analysis
will be used. All outcomes may be measured quantita-
tively or qualitatively.
Risk of bias individual studies
Risk of bias of predominantly quantitative studies will be
assessed by the Checklist for Measuring Quality by
Downs and Black.14 The checklist contains 27 yes/no
questions across ﬁve constructs: study quality (the overall
quality of the study); external validity (the ability to gen-
eralise ﬁndings of the study); study bias (to assess bias in
the intervention and outcome measure(s)); confound-
ing and selection bias (to determine bias from sampling
or group assignment); and power of the study (to deter-
mine if ﬁndings are due to chance).14 Risk of bias of
predominantly qualitative studies will be assessed by the
JBI Critical Appraisal Checklist for Qualitative Research,
which consists of 10 questions that can be answered with
yes, no, unclear or not applicable.15
The risk of bias will be assessed for all applicable
studies in duplicate by two independent reviewers
(LWMEB and MLAPS), without blinding. To increase
consistency between the reviewers, the checklists will be
pilot tested before the start of the risk of bias assessment
of the review. This will be carried out by duplicate assess-
ment of two CP-related records (one predominantly
quantitative study and one predominantly qualitative
study), which are not eligible for inclusion in this review.
In case of disagreement between reviewers during the
review, a third and fourth reviewer (YJJ-P and BS) will
arbitrate. Risk of bias will be assessed on the study level.
Results across studies will be presented graphically.
Additionally, the reviewers will state how the risk of bias
may have inﬂuenced their review ﬁndings.
Data synthesis
Based on the results of the article of Novak et al,7 a
limited number of efﬁcacy and effectiveness studies are
expected to be found by the systematic search.
Additionally, the studies are expected to be both clinic-
ally and methodologically heterogeneous. Hence, it is
anticipated that conducting a meta-analysis will not be
appropriate. Therefore, a method for meta-analysis is
not included in this protocol. If the assumption emerges
to be wrong, this will result in an amendment of the
protocol, in which a method for meta-analysis will be
included. An amendment will be made if at least three
efﬁcacy and effectiveness studies are comparable regard-
ing treatment, comparator(s) and outcome(s).16 The
reviewers (LWMEB, MLAPS, YJJ-P and BS) will decide
whether a meta-analysis is appropriate and report the
rationale.
Meta-biases
For the efﬁcacy and effectiveness studies included in the
review, the risk of selective reporting (outcome reporting
bias) will be determined. This will be assessed by com-
paring the records on study results with previously pub-
lished study protocols and registrations. The studies of
which no study protocol or trial registration was found
will also be listed. This procedure will be performed by
one reviewer (LWMEB).
In case of ≥10 homogeneous efﬁcacy and effectiveness
studies (according to the criteria described in the para-
graph ‘data synthesis’), risk of publication bias will be
assessed by graphing a funnel plot and, if appropriate,
supplemented by a statistical test. In the plot, it will be
indicated which studies have been published in a
journal and which ones have not been (yet).
Confidence in cumulative estimate
For each efﬁcacy and effectiveness outcome, the
Grading of Recommendations Assessment, Development
and Evaluation (GRADE) guidelines will be used to
judge the quality of evidence within the domains risk of
bias, publication bias, imprecision, inconsistency and
indirectness.17 The quality of the evidence can be
scored as high quality (very conﬁdent that the true
effect lies close to that of the estimate of the effect),
moderate quality (moderately conﬁdent in the effect
estimate: the true effect is likely to be close to the esti-
mate of the effect, but there is a possibility that it is sub-
stantially different), low quality (conﬁdence in the effect
estimate is limited: the true effect may be substantially
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different from the estimate of the effect) or very low
quality (very little conﬁdence in the effect estimate: the
true effect is likely to be substantially different from the
estimate of effect). The same approach as described in
the paragraph ‘risk of bias individual studies’ will be
used for pilot testing and scoring.
Amendments
In case of protocol amendments, the authors will docu-
ment the date, description of the changes and rationale
for each amendment.
ETHICS AND DISSEMINATION
Ethical considerations
The proposed study does not involve collection of primary
data. Accordingly, no ethical approval is required.
DISSEMINATION PLAN
This systematic review protocol was registered in the
International Prospective Register of Systematic Reviews
(PROSPERO) on 29 July 2016 (registration number
CRD42016043743).
The authors will disseminate the ﬁndings of this
review through publication in a peer-reviewed journal and
conference presentation(s). The results will be reported
according to the most recent version of the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA).18
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